Holen Sie sich die Stockscreener-App
36.54
0.29%
-0.1069
Schlusskurs vom Vortag:
$36.64
Offen:
$37.18
24-Stunden-Volumen:
17,026
Relative Volume:
0.46
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.72%
1M Leistung:
+1.41%
6M Leistung:
+42.88%
1J Leistung:
+46.40%
1-Tages-Spanne:
$36.43
$37.18
1-Wochen-Bereich:
$35.66
$37.18
52-Wochen-Spanne:
$20.10
$37.51
Tema Oncology Etf Stock (CANC) Company Profile
Firmenname
Tema Oncology Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare CANC vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
36.54 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
336.01 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
681.27 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.33 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
272.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
600.64 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf Aktie (CANC) Neueste Nachrichten
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC - Defense World
(CANC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Responsive Playbooks and the CANC Inflection - Stock Traders Daily
Understanding the Setup: (CANC) and Scalable Risk - Stock Traders Daily
Tema Oncology ETF (NQ: CANC - FinancialContent
Here's Why Biotech ETFs Are Rallying Hard - Zacks Investment Research
Los Angeles Daily NewsTema Oncology ETF (Nasdaq:CANC) Stock Quote - FinancialContent
The Technical Signals Behind (CANC) That Institutions Follow - Stock Traders Daily
Trading Systems Reacting to (CANC) Volatility - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (CANC) Movement - Stock Traders Daily
ETFs Investing in Ascentage Pharma Group International Unsponsored ADR Stocks - TradingView — Track All Markets
Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year. - Yahoo Finance
Discipline and Rules-Based Execution in CANC Response - news.stocktradersdaily.com
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - PharmiWeb.com
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Sahm
Be Thankful to These ETFs This Year - sharewise.com
Behavioral Patterns of CANC and Institutional Flows - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
(CANC) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How (CANC) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
Tema Launches Alternative Asset Managers ETF (AAUM) - Business Wire
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Tema Launches First International Defense Innovation ETF (GDFN) - Business Wire
Short Interest in Tema Oncology ETF (NASDAQ:CANC) Increases By 264.8% - Defense World
Tema Launches International Durable Quality ETF (ITOL) - Business Wire
Tema Etfs LLC Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Tema Announces Liquidation of Two ETFs - Business Wire
5 Small-cap Biotech ETFs to Watch - Nasdaq
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
AAPG Stock Price and Chart — NASDAQ:AAPG - TradingView
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
TEMA ONCOLOGY ETF(NASDAQ:CANC) stock Stock Chart - Chartmill
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tema ETF Trust Tema Oncology ETF (NASDAQ: CANC)Related Research - intelligentinvestor.com.au
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
CANC Financial Statements & ChartsTema Etf TrustTema Oncology Etf MacroTrends - CMLviz
Tema Neuroscience And Mental Health ETF (MNTL) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Holdings - Yahoo! Finance Canada
Tema Oncology ETF (CANC) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Stock Trends and Sentiment 2025 - MarketBeat
Tema ETFs CIO on Investment Opportunities in Biotech - CMC Markets
Finanzdaten der Tema Oncology Etf-Aktie (CANC)
Es liegen keine Finanzdaten für Tema Oncology Etf (CANC) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):